Cargando…

Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis

BACKGROUND: Currently accepted therapies for ragweed allergy in North America consist of pharmacotherapy and subcutaneous allergen immunotherapy injections to treat symptoms. Allergen immunotherapy not only reduces symptoms and the need for pharmacotherapy but has also been shown to have disease-mod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Harold, Waserman, Susan, Hébert, Jacques, Blaiss, Michael, Nelson, Harold, Creticos, Peter, Kaur, Amarjot, Maloney, Jennifer, Li, Ziliang, Nolte, Hendrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363352/ https://www.ncbi.nlm.nih.gov/pubmed/25788949 http://dx.doi.org/10.1186/1710-1492-10-55

Ejemplares similares

Efficacy and safety of standardized short ragweed sublingual immunotherapy tablet (SLIT-T) treatment in Canadian subjects with ragweed pollen-induced rhinitis with or without conjunctivitis
por: Blaiss, Michael, et al.
Publicado: (2014)

The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children
por: Hébert, Jacques, et al.
Publicado: (2014)

Efficacy and safety of MK-7243: a grass allergy sublingual immunotherapy tablet evaluated in Canadian adults and children
por: Hébert, Jacques, et al.
Publicado: (2014)

Efficacy of Timothy grass allergy immunotherapy tablet (AIT) treatment in Canadian children and adults with grass pollen-induced allergic rhinoconjunctivitis (ARC)
por: Hebert, Jacques, et al.
Publicado: (2011)

Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis
por: Ellis, Anne K., et al.
Publicado: (2021)

The effect of the ragweed sublingual immunotherapy tablet MK-3641 on rescue medication use
por: Gawchik, Sandra, et al.
Publicado: (2014)

The efficacy and safety of the short ragweed sublingual immunotherapy tablet MK-3641 is similar in asthmatic and nonasthmatic subjects treated for allergic rhinitis with/without conjunctivitis
por: Maloney, Jennifer, et al.
Publicado: (2014)

Efficacy of short-ragweed sublingual immunotherapy tablet MK-3641 in monosensitized and polysensitized subjects
por: Bernstein, David I, et al.
Publicado: (2014)

Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
por: Ellis, Anne K., et al.
Publicado: (2023)

A practical guide to prescribing sublingual immunotherapy tablets in North America for pediatric allergic rhinoconjunctivitis: an injection-free allergy immunotherapy option
por: Blaiss, Michael, et al.
Publicado: (2023)

Ragweed-induced allergic rhinoconjunctivitis: current and emerging treatment options
por: Ihler, Friedrich, et al.
Publicado: (2015)

“The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis”
por: Demoly, Pascal, et al.
Publicado: (2015)

161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
por: Cox, Linda, et al.
Publicado: (2012)

A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis
por: Devillier, Philippe, et al.
Publicado: (2014)

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
por: Malling, H-J, et al.
Publicado: (2009)

Allergic rhinoconjunctivitis
por: Miraglia del Giudice, Michele, et al.
Publicado: (2020)

Magnitude of changes in patient symptom and medication scores in grass allergy immunotherapy trials: dependency on levels of pollen exposure
por: Nolte, Hendrik, et al.
Publicado: (2014)

PD14 - Non-interventional 2-year study of sublingual immunotherapy in children and adolescents with allergic rhinoconjunctivitis caused by grass pollen
por: Karagiannis, Efstrathios, et al.
Publicado: (2014)

Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis
por: Proctor, Thomas, et al.
Publicado: (2020)

Current status of sublingual immunotherapy in the United States
por: Elenburg, Shelby, et al.
Publicado: (2014)

Sublingual immunotherapy with a carbamylated monomeric allergoidin cat-allergic patients suffering from rhinoconjunctivitis and/or allergic asthma. A multicenter, cross-sectional survey
por: Hauswald, Bettina
Publicado: (2015)

Treatment Satisfaction During Sublingual Immunotherapy with a Five-Grass Pollen Tablet for Allergic Rhinoconjunctivitis: A Prospective, Non-Interventional Study
por: Schäfer, Udo, et al.
Publicado: (2017)

Diagnosis of nasal and eye allergies: the Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) patient survey
por: Blaiss, Michael, et al.
Publicado: (2014)

Development and Validation Features of the Patient Benefit Index for the Treatment of Allergic Rhinoconjunctivitis with Allergen Immunotherapy
por: Langenbruch, Anna, et al.
Publicado: (2022)

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2016)

Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis
por: Penagos, Martin, et al.
Publicado: (2018)

Sublingual immunotherapy in allergic rhinitis
por: Han, Doo Hee, et al.
Publicado: (2011)

Allergic Rhinoconjunctivitis: the Role of Histamine
por: Andersson, M., et al.
Publicado: (1994)

Bilastine for allergic rhinoconjunctivitis, urticaria
Publicado: (2022)

Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2017)

Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews
por: Nurmatov, Ulugbek, et al.
Publicado: (2017)

Efficacy of house dust mite sublingual tablet in the treatment of allergic rhinoconjunctivitis: A randomized trial in a pediatric population
por: Okamoto, Yoshitaka, et al.
Publicado: (2018)

Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy
por: Poole, Chris D, et al.
Publicado: (2014)

29 Allergic Rhinitis to Ragweed Pollen
por: Bocsan, Ioana Corina, et al.
Publicado: (2012)

Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
por: Tsabouri, Sophia, et al.
Publicado: (2017)

Relationship between allergic rhinitis and allergic conjunctivitis (allergic rhinoconjunctivitis) - review
por: Iordache, Andreea, et al.
Publicado: (2022)

Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Ragweed pollen concentration predicts seasonal rhino-conjunctivitis and asthma severity in patients allergic to ragweed
por: Bonini, Maira, et al.
Publicado: (2022)

Poster 1000: Efficacy and safety of specific sublingual immunotherapy with carbamylated allergoid tablets of ragweed pollen: a dose-ranging study
por: Compalati, Enrico, et al.
Publicado: (2014)

Corrigendum: Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
por: Tsabouri, Sophia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ml79sbsqurtirkoaghkjramh9s